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Dear Editor,
In immunocompromised patients, coagulase-negative
Staphylococci (CoNS) have emerged as a major cause of
infection, especially in those with indwelling foreign bodies
[9, 10]. Herein, we present a case of septic arthritis caused
by CoNS in a neutropenic patient.
A 29-year-old-male patientwas diagnosed withcommonT-
cell acute lymphoblastic leukemia after a brief period of sore
throat, night sweats, and progressive lymphadenopathy. On
February152007,acentralvenouscatheterwasplaced,andon
the next day, induction chemotherapy was initiated (vincristin,
daunorubicin, cyclophosphamide, L-asparaginase, intrathecal
methotrexate, prednisone). Antimicrobial prophylaxis con-
sisted of colistin, trimethoprim-sulfamethoxazol, and fluco-
nazol. On day 22, he experienced an episode of neutropenic
fever, having 0.3×10
9 neutrophils/L. Blood cultures were
obtained and empiric therapy with vancomycin, and ceftazi-
dim was initiated. On day 27, one out of four microbial blood
cultures appeared positive for CoNS. Because the fever had
subsided and neutrophil count returned to normal, antibiotic
treatment was discontinued, and the patient was discharged
after removal of the central venous catheter. On March 27,
consolidation therapy was initiated (6-thioguanine, cyclo-
phosphamide, subcutaneous cytarabine, intrathecal metho-
trexate) in the outpatient clinic. On day 29, however, he was
admitted for evaluation and treatment of neutropenic fever
(0.42×10
9 neutrophils/L) and severe pain in the left inguinal
area, with impaired range of left hip movement. Physical
examination revealed no swelling or edema of his left
inguinal and hip area. There were no heart murmurs or other
abnormalities. Empiric antibiotic treatment with flucloxacillin
and gentamicin was initiated. Conventional radiography and
magnetic resonance imaging showed normal bony config-
urations and little joint fluid and synovitis of the left hip. An
arthrotomy with joint lavage was performed, showing
hypertrophied capsule but no fluid, pus, or cartilage damage.
One of four lavage fluid cultures turned out positive for
CoNS. Because there were no indwelling foreign bodies and
the clinical aspect of the hip was near normal during
arthrotomy, the CoNS were considered as culture contami-
nants. Symptoms persisted despite empiric antibiotic therapy
with flucloxacillin and, eventually, vancomycin treatment was
initiated, resulting in a decrease of plasma C-reactive protein
(CRP) levels. Because of persistent pain symptoms, a decision
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Arnhem, the Netherlandswas made to perform a Girdlestone resection arthroplasty of
the hip. Cultures taken during surgery (June 22) from the
acetabulum, femur, and joint cartilage were all positive for
Staphylococcus epidermidis. The strain cultured from the hip
joint was apparently identical to the strain obtained from
previous cultures, based on the susceptibility pattern of the
different strains (Table 1). The patient was treated with
vancomycin and rifampicin, following the susceptibility
pattern, which resulted in normalization of the CRP.
There are few cases reported in the literature of invasive
infections caused by CoNS in immunocompromised
patients. Native valve endocarditis caused by S. epidermidis
has been described in a patient who was misdiagnosed with
arteritis temporalis and subsequently treated with high dose
prednisone [8], a patient with myelodysplasia and a
Mediport [6], and a patient with AIDS and an indwelling
dialysis catheter [6]. S. epidermidis arthritis has been
described before in a patient with acute lymphocytic
leukemia, 6 weeks after evident S. epidermidis bacteremia
[4]. Other S. epidermidis infections in patients with acute
leukemia include necrotizing dermatitis [3], mandibular
osteomyelitis [1], and even septic meningitis [7]a n d
pneumosepsis [2]. Finally, Staphylococcus cohnii has been
identified as the causative pathogen in a HIV-positive
patient with community-acquired pneumonia [5].
The most important observation made in our patient and
in others is that although CoNS infections are associated
with mild clinical symptoms in the majority of cases, it is,
in fact, able to cause severe infections, sometimes weeks
after the initial bacteremia and removal of the central
venous catheter. The culture of S. epidermidis should
always be considered potentially hazardous in immuno-
compromised patients and may necessitate prompt treat-
ment. In future studies on CoNS-related complications,
both combination of antibiotics (as opposed to monother-
apy) and duration of therapy should be investigated.
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Table 1 Susceptibility patterns of the different Staphylococcus
epidermidis strains cultured over time
Staphylococcus
epidermidis
Blood
culture
Fluid left
hip
Cartilage
left hip
Capsule
left hip
MAR 08
2007
MAR 17
2007
JUNE 22
2007
JUNE 22
2007
Penicillin 0 0 0 0
Flucloxacillin 0 0 0 0
Tetracyclin + + + +
Gentamicin 0 0 0 0
Sulfamethoxazol 0 0 0 0
Trimethoprim 0 0 0 0
Erythromycin 0 0 0 0
Clindamycin 0 0 0 0
Rifampicin + + + +
Vancomycin + + + +
Fusidic acid 0 0 0 0
Tobramycin 0 0 0 0
Ciprofloxacin 0 0 0 0
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